Literature DB >> 15500447

Proteolytic processing and glycosylation influence formation of porcine prion protein complexes.

Krzysztof Nieznanski1, Marcin Rutkowski, Magdalena Dominik, Dariusz Stepkowski.   

Abstract

High level of heterogeneity seems to be a ubiquitous feature of mammalian PrPs (prion proteins) and may be relevant to the pathogenesis of prion diseases. In the present study, we describe the heterogeneity of PrP(C) (cellular form of PrP) from porcine brain. It was disclosed and characterized by a combination of one-dimensional PAGE and two-dimensional PAGE analyses with enzymic deglycosylation and copper-affinity experiments. We found that the identified two main populations of porcine PrP(C) consist of diglycosylated forms and correspond to the full-length (molecular mass 32-36 kDa) and proteolytically modified protein (molecular mass 25-30 kDa), known as C1. The two populations were fully separated during Cu2+-loaded immobilized metal affinity chromatography, indicating different affinity for copper ions. The more basic forms, migrating as species of higher molecular mass, exhibited stronger affinity for copper ions, whereas those with more acidic pI and of lower molecular mass were low-affinity Cu2+-binding molecules and thus could represent N-terminally truncated PrP(C). Size-exclusion chromatography revealed that most of the PrP(C) molecules in porcine brain extracts exist in the form of high-molecular-mass complexes (probably with other proteins). The heterogeneity of porcine PrP(C), resulting from proteolytic modification and glycosylation, influences its ability to assemble into these complexes. N-truncated molecules dominate over full-length PrP(C) in fractions of molecular mass over the range 65-130 kDa, whereas the full-length species are the major forms of PrP(C) present in the monomeric fraction and in complexes above 130 kDa. Two-dimensional PAGE analysis indicated that the complexed PrP(C) differs in the composition of pI forms from the monomers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15500447      PMCID: PMC1134936          DOI: 10.1042/BJ20041344

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Antioxidant activity related to copper binding of native prion protein.

Authors:  D R Brown; C Clive; S J Haswell
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

2.  The cellular prion protein colocalizes with the dystroglycan complex in the brain.

Authors:  G I Keshet; O Bar-Peled; D Yaffe; U Nudel; R Gabizon
Journal:  J Neurochem       Date:  2000-11       Impact factor: 5.372

3.  Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor.

Authors:  C Hundt; J M Peyrin; S Haïk; S Gauczynski; C Leucht; R Rieger; M L Riley; J P Deslys; D Dormont; C I Lasmézas; S Weiss
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

4.  Copper binding to the PrP isoforms: a putative marker of their conformation and function.

Authors:  Y Shaked; H Rosenmann; N Hijazi; M Halimi; R Gabizon
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  A monomer-dimer equilibrium of a cellular prion protein (PrPC) not observed with recombinant PrP.

Authors:  R K Meyer; A Lustig; B Oesch; R Fatzer; A Zurbriggen; M Vandevelde
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

6.  Prion protein binds copper within the physiological concentration range.

Authors:  M L Kramer; H D Kratzin; B Schmidt; A Römer; O Windl; S Liemann; S Hornemann; H Kretzschmar
Journal:  J Biol Chem       Date:  2001-02-27       Impact factor: 5.157

7.  The neuropathology of experimental bovine spongiform encephalopathy in the pig.

Authors:  S J Ryder; S A Hawkins; M Dawson; G A Wells
Journal:  J Comp Pathol       Date:  2000 Feb-Apr       Impact factor: 1.311

8.  The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein.

Authors:  B Vincent; E Paitel; P Saftig; Y Frobert; D Hartmann; B De Strooper; J Grassi; E Lopez-Perez; F Checler
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

9.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

Authors:  J Collinge; K C Sidle; J Meads; J Ironside; A F Hill
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

10.  Novel differences between two human prion strains revealed by two-dimensional gel electrophoresis.

Authors:  T Pan; M Colucci; B S Wong; R Li; T Liu; R B Petersen; S Chen; P Gambetti; M S Sy
Journal:  J Biol Chem       Date:  2001-08-06       Impact factor: 5.157

View more
  2 in total

1.  Separation of native prion protein (PrP) glycoforms by copper-binding using immobilized metal affinity chromatography (IMAC).

Authors:  Henrik Müller; Alexander Strom; Gerhard Hunsmann; Andreas W Stuke
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

Review 2.  Prion Protein: The Molecule of Many Forms and Faces.

Authors:  Valerija Kovač; Vladka Čurin Šerbec
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.